We’re excited to announce a new partnership with uMed to move clinical research out of the lab and into the community 🔬 🧬 By connecting our national home care network with uMed’s platform, we’re bridging the gap between frontline care and life-changing science: Cera provides the insight – drawing on our world-leading dataset to rapidly and safely identify the people who would most benefit from access to trials, and match them with the right research 📊 uMed handles registration – taking care of everything from reaching out to patients to helping them sign up. It’s a safe, ethical, and easy way to join a study without the usual stress 📲 Together, we’re making research work for everyone by removing the old barriers: 🏠 Home-first access – no more stressful travel to hospitals. People can participate from the comfort of their own living room. 🤝 Built-in support – tackling digital exclusion as our frontline teams are there to help, so technology is a bridge, not a barrier. 💡 Awareness – reaching the populations who are often overlooked, ensuring research finally focuses on those who need it most. We’re ensuring that more people have the opportunity to participate in research, no matter their age or location 🏘️ 🔗 Read more about the partnership in Health Tech World: https://lnkd.in/ewsBRUrc #ClinicalTrials #DecentralisedTrials #HealthcareResearch #HealthTech #TeamCera #PatientAccess Cera Trials at Home
Cera Partners with uMed for Decentralized Clinical Trials
More Relevant Posts
-
A really exciting piece of news today. The combined strengths of the teams at Ametris (formerly ActiGraph) and Signant Health will be hard to beat.
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
An important day for Ametris, Signant, and the whole industry. Bringing validated DHT‑derived endpoints together with eCOA on a single platform is a real step toward richer, more connected clinical evidence. This is more than the integration of complementary technologies—it creates the opportunity for sponsors to rethink endpoint strategy around a fuller, more continuous patient picture. I feel fortunate to be part of this and genuinely optimistic about what’s ahead.
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
Big news at Signant Health today — we officially acquired Ametris (formerly ActiGraph), bringing wearable-derived digital outcome measures together with our eCOA platform to create a truly end-to-end evidence generation solution for clinical trials. Exciting time to be part of this team! If you or someone in your network works in clinical technology or digital health, let's connect.
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
Today marks an exciting new chapter for Ametris. For more than two decades, this team has worked to help clinical research move beyond episodic, site-based measurement and toward a deeper understanding of how patients function in their daily lives. Joining Signant Health gives us the opportunity to accelerate that mission. Together, we are bringing together two important sources of evidence: what patients report, and what their bodies show through validated, wearable-derived digital measures. That combination has the potential to simplify complex studies, strengthen efficacy cases, and help sponsors better understand meaningful treatment benefit. I’m incredibly proud of the Ametris team and grateful for the customers, partners, advisors, and investors who helped build this company into what it is today. Excited for what comes next as we continue advancing the future of digital health in clinical research.
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
📣 Excited to share that Ametris (formerly ActiGraph) has been acquired by Signant Health. Together, we’re building an end-to-end eCOA and wearable platform that brings together what patients say and what their bodies show — unifying patient-reported outcomes with continuous digital measures. I’m proud to be a part of this team and excited for what’s ahead as we continue advancing patient-centric, data-driven clinical research. #ClinicalResearch #DigitalHealth #eCOA #Wearables #EvidenceGeneration #ClinicalTrials #DHT #pharma #biotech
An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signant Health company. This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant Health are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial execution. Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data. Read the full announcement to learn more: https://hubs.la/Q04gBGSs0
-
-
Good practice need not to stay within the four corners of the clinic. Time to share means and ways to #activait full potential using sound and scientific methodology and dissemination.
At Activait, evidence-based practice means more than applying research. It means contributing to it. Congratulations to our CEO/Founder, Doc Anj Borras Maria Angela B. for receiving the Best Research Paper Award at the 1st International Conference on Life Sciences and Multidisciplinary Healthcare Approaches (ICLSMHA 2026). As clinicians, we believe healthcare should not rely on trends, assumptions, or guesswork. We move with science — continuously learning, questioning, and creating knowledge that improves how people move, recover, and live. This is the standard we uphold at Activait. Producing science-driven intervention. Patient-centered care. Future-focused health systems. #activaitph #activaiteverybody #GainsSansPain #servantleadership
-
-
Clinical research is changing rapidly — and CHCRC is building the exact community-centered, technology-enabled infrastructure the FDA, sponsors, and CROs are increasingly seeking. With a projected network exceeding 500,000 active patients across highly diverse urban, suburban, rural, and underserved populations, CHCRC combines real-world patient access with centralized CRIO eSource systems, real-time oversight, Inato-integrated feasibility engagement, standardized operations, and decades of executive and CRC experience. By integrating research directly into trusted Community Health Centers, CHCRC is helping create a future where diversity, operational consistency, patient trust, and scalable enrollment are no longer competing goals — but part of one unified clinical research ecosystem.
-
-
Joining Nicholas in Copenhagen for HIMSS26 Europe 🇩🇰 At Promptly Health, we are partnering with tech companies to unlock real-world health data through federated, OMOP-based harmonization. If you're building in health IT, clinical analytics or life sciences infrastructure and want to explore what a tech partnership looks like, let's find time to connect at HIMSS. #HIMSSEurope #HIMSS26EU #HIMSS26Europe #HealthTech #HealthData #DigitalHealth
Strategic Partnerships | Real-World Evidence | Federated Health Data | Data Network Lead | Medical Imaging & AI
Heading to Copenhagen next week for HIMSS Europe with Olívia Oliveira. Excited to exchange on how the European healthtech ecosystem is preparing for an EHDS-ready future, and what a federated, multi-country evidence network actually needs to look like to deliver on that promise. The data layer is far from solved. Interoperability, governance, quality, structured PRO capture across markets. All still very real problems for teams building digital health platforms, EHRs and AI tools in Europe. At Promptly Health that's where we think the most interesting conversations live right now: among teams who see federated evidence and RWE/PRO infrastructure as a need, not a downstream concern. If you're at HIMSS and working in this space, I'd love to grab time. Let's connect. #HIMSS26Europe
-
-
🙌 TEAMWORK makes the DREAMWORK! Thrilled to see our tech scale the continued expansion of Multiple Sclerosis Association of America (MSAA) and its Multiple Sclerosis Implementation Network® (MSIN®) as the initiative reaches 💥 1,200+ participants across 20 locations 💥 in the United States 🇺🇸. At SEQSTER, we believe advancing research starts with making health data more connected, accessible, and actionable. By helping unify fragmented medical records and patient-generated data, we’re enabling research initiatives like MSIN® to scale more efficiently and deepen insights into multiple sclerosis care and outcomes. This milestone reflects the power of collaboration between patients, providers, researchers, and technology partners working toward better care for people living with #MS. 👇Read the official press release in my comments below. #Healthcare #Innovation #DigitalHealth #RealWorldData #MultipleSclerosis #Interoperability #ClinicalResearch #HealthTech #PatientCentricity
-
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development